275 related articles for article (PubMed ID: 12361815)
1. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
[TBL] [Abstract][Full Text] [Related]
2. Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin.
Dinubile MJ; Lupinacci RJ; Berman RS; Sable CA
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):903-8. PubMed ID: 12230933
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.
Kartsonis N; DiNubile MJ; Bartizal K; Hicks PS; Ryan D; Sable CA
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):183-7. PubMed ID: 12394797
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis.
Villanueva A; Arathoon EG; Gotuzzo E; Berman RS; DiNubile MJ; Sable CA
Clin Infect Dis; 2001 Nov; 33(9):1529-35. PubMed ID: 11588698
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.
Arathoon EG; Gotuzzo E; Noriega LM; Berman RS; DiNubile MJ; Sable CA
Antimicrob Agents Chemother; 2002 Feb; 46(2):451-7. PubMed ID: 11796357
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Barbaro G; Barbarini G; Di Lorenzo G
Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
[TBL] [Abstract][Full Text] [Related]
8. Caspofungin in the treatment of oropharyngeal candidiasis.
Garbino J; Lew D; Hirschel B; Rohner P
Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Barbarini G; Di Lorenzo G
Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
Laine L; Dretler RH; Conteas CN; Tuazon C; Koster FM; Sattler F; Squires K; Islam MZ
Ann Intern Med; 1992 Oct; 117(8):655-60. PubMed ID: 1308663
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
Keating G; Figgitt D
Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin acetate: an antifungal agent.
Hoang A
Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878
[TBL] [Abstract][Full Text] [Related]
14. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
de Wet NT; Bester AJ; Viljoen JJ; Filho F; Suleiman JM; Ticona E; Llanos EA; Fisco C; Lau W; Buell D
Aliment Pharmacol Ther; 2005 Apr; 21(7):899-907. PubMed ID: 15801925
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Krause DS; Simjee AE; van Rensburg C; Viljoen J; Walsh TJ; Goldstein BP; Wible M; Henkel T
Clin Infect Dis; 2004 Sep; 39(6):770-5. PubMed ID: 15472806
[TBL] [Abstract][Full Text] [Related]
18. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
19. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
[TBL] [Abstract][Full Text] [Related]
20. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]